Skip to content
New: free dose calculator with 14 peptide presets. No signup.
Peptides Academy

Tesamorelin + CJC-1295/Ipamorelin Fat Loss Stack

Tesamorelin and CJC-1295/Ipamorelin both target the GH axis but through complementary timing and receptor profiles. Tesamorelin has FDA-level RCT evidence for visceral fat reduction; CJC-1295/Ipamorelin amplifies nocturnal GH pulsatility for broader body composition support. The combination intensifies GH-mediated lipolysis across the day/night cycle.

Quick Comparison

PropertypeptideThe Fat Loss Stack: Tesamorelin + CJC-1295/Ipamorelin
SourceSalmon DNA fragmentsVarious sources
Primary MechanismA2A receptor activation, DNA repairVaries by ingredient
Key BenefitsTissue regeneration, anti-inflammation, collagen boostMultiple skin benefits
Best Time to ApplyAM or PMAM or PM
Can Combine?Generally compatible — check specific guidelines.

How to Use Together

Tesamorelin 2 mg subcutaneously once daily in the morning (to leverage the diurnal GH pattern and avoid stacking with nocturnal pulse). CJC-1295 (no DAC) 100 mcg + Ipamorelin 100 mcg subcutaneously 30–60 minutes before bed on an empty stomach. The separation ensures distinct GH pulses rather than continuous elevation. Cycle: 8–12 weeks, with IGF-1 monitoring at baseline and 4–8 weeks.

Safety Notes

Both arms elevate IGF-1, which has theoretical cancer-promotion concerns at sustained supraphysiological levels. Monitor IGF-1 and maintain within upper-normal range for age. GH elevation can worsen insulin sensitivity — monitor fasting glucose and A1C. Contraindicated in active malignancy and uncontrolled diabetes. Water retention (edema, joint stiffness) is the most common side effect and usually resolves with time or dose reduction.

Recommended Products (3)

Frequently Asked Questions

Why combine Tesamorelin with CJC-1295/Ipamorelin instead of using one or the other?
Tesamorelin is a GHRH analog dosed in the morning for daytime GH support and has the strongest visceral fat evidence. CJC-1295/Ipamorelin pre-bed targets the nocturnal GH pulse that is most important for recovery and body composition. The separated timing creates two distinct GH pulses per day — closer to the polyphasic GH pattern of a younger individual.
How much fat loss should I realistically expect?
Tesamorelin trials showed ~15% visceral fat reduction over 26 weeks. CJC-1295/Ipamorelin body composition effects are modest — expect 1–3 kg fat loss over 8–12 weeks from the GH component alone. These peptides enhance caloric-deficit-driven fat loss; they don't replace it. Diet and exercise remain the primary drivers.
Why not just use a GLP-1 agonist instead?
GLP-1s (semaglutide, tirzepatide) produce much larger total weight loss (15–22%). However, they also cause significant lean mass loss (~40% of weight lost). The GH-axis stack is chosen by individuals who want more targeted fat loss with lean mass preservation. The approaches are not mutually exclusive — some protocols combine both.
Can I add AOD-9604 to this stack?
AOD-9604 targets lipolysis through a different mechanism (GH fragment, beta-3 adrenergic pathway) and can theoretically complement GH-axis stimulation. However, adding a third GH-pathway compound increases complexity without proportional evidence of benefit. If the GH stack alone isn't producing results, audit diet and exercise compliance before adding compounds.
What is the best way to measure progress with this stack?
DEXA scan at baseline and week 12 is the gold standard — it separates visceral fat, subcutaneous fat, and lean mass changes. Waist circumference measured weekly (morning, fasted, same conditions) is a practical proxy for visceral fat. Scale weight alone is misleading because GH peptides can cause water retention and lean mass changes that mask fat loss on the scale.
Is fasting required for injection timing?
Yes, for the CJC-1295/Ipamorelin pre-bed dose — GH release from GHRH and GHRP agonists is blunted by elevated blood glucose and insulin. Wait at least 2 hours after your last meal before injecting. The morning Tesamorelin dose should also be on an empty stomach when possible. Food and sugar consumed near injection time will reduce the GH pulse magnitude, directly undermining the protocol's purpose.
Should women use different doses for this stack?
The core protocol is similar for both sexes, though some practitioners use slightly lower CJC-1295/Ipamorelin doses in women (75 mcg each vs 100 mcg). Women naturally have higher basal GH secretion than men (due to estrogen's stimulatory effect on GH) but lower IGF-1 levels. The monitoring thresholds are the same — keep IGF-1 in the upper-normal range for age. Menstrual cycle phase can affect GH responsiveness; some protocols time initiation with the follicular phase.

Other peptide Ingredient Combinations

The Anti-Aging Stack: GHK-Cu + Epitalon

GHK-Cu and Epitalon target two distinct hallmarks of aging — extracellular matrix degradation and te

The Athletic Performance Stack: IGF-1 LR3 + Ipamorelin + BPC-157

The athletic performance stack layers three peptides with distinct but complementary mechanisms to s

The Cardiac Protection Stack: TB-500 + SS-31 + Humanin

A three-peptide cardiovascular support stack targeting myocardial repair (TB-500), mitochondrial car

The Cognitive Stack: Semax + Selank

The classic Russian nootropic peptide pairing. Semax (an ACTH 4-10 analog) enhances BDNF expression

The GH Stack: CJC-1295 + Ipamorelin

The dual-pathway growth-hormone stack. CJC-1295 (GHRH analog) opens the pituitary somatotroph; Ipamo

The Gut Healing Stack: BPC-157 + KPV + Larazotide

The gut healing stack combines three peptides targeting distinct aspects of intestinal repair: BPC-1

The Hair Restoration Stack: GHK-Cu + Thymosin Beta-4

GHK-Cu and Thymosin Beta-4 (TB-500) target complementary mechanisms in hair follicle biology — coppe

The Healing Stack: BPC-157 + TB-500

The canonical regenerative-peptide pairing. BPC-157 and TB-500 operate through non-overlapping biolo

Immune Support Stack

A combination approach targeting immune function through three complementary mechanisms: adaptive im

The Joint Repair Stack: BPC-157 + Pentosan Polysulfate + TB-500

A comprehensive joint-repair protocol targeting all layers of joint pathology: BPC-157 for periartic

The Longevity Stack: Epitalon + MOTS-c + SS-31

Three peptides targeting different hallmarks of aging: Epitalon for telomerase activation and pineal

The Metabolic Stack: GLP-1 + GHS

A newer 'metabolic recomposition' pairing some practitioners use: a GLP-1 agonist for appetite and t

The Neuroprotection Stack: Cerebrolysin + Semax + Pinealon

The neuroprotection stack combines three neuropeptide approaches with complementary mechanisms — cer

The Nootropic Stack: Semax + Selank + GH-Axis Support

A three-tier nootropic peptide stack targeting cognitive performance through complementary mechanism

The Post-Surgery Recovery Stack: BPC-157 + TB-500 + Thymosin Alpha-1

The post-surgery recovery stack combines the established BPC-157 + TB-500 tissue-repair pairing with

The Sexual Health Stack: PT-141 + Kisspeptin-10

PT-141 and Kisspeptin-10 target complementary aspects of sexual function — central desire pathways a

The Skin Rejuvenation Stack: GHK-Cu + GH-Axis + Collagen

A multi-level skin rejuvenation protocol combining topical signaling (GHK-Cu), systemic GH-axis elev

The Sleep Stack: DSIP + Ipamorelin

DSIP (Delta Sleep-Inducing Peptide) and ipamorelin target complementary aspects of sleep optimizatio

The Stress Resilience Stack: Selank + DSIP + Semax

A three-peptide stack targeting different dimensions of the stress response: Selank for anxiolysis a

The Weight Loss Stack: Semaglutide/Tirzepatide + Tesamorelin

This weight loss stack combines GLP-1 receptor agonist therapy (semaglutide or tirzepatide) with the

The Women's Hormonal Stack: Kisspeptin + BPC-157 + Thymosin Alpha-1

A three-peptide combination addressing women's hormonal health through hypothalamic signaling restor

Browse All peptide Products

Search

Search across products, blog posts, wiki articles, and more.